We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.78%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$17.4B
AUM Growth
+$1.04B
(+6.3%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
0.7%
Top 10 Holdings %
Top 10 Hldgs %
21.21%
Holding
1,119
New
175
Increased
316
Reduced
445
Closed
162
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$176M |
| 2 |
Airbnb
ABNB
|
+$145M |
| 3 |
Mastercard
MA
|
+$132M |
| 4 |
Edwards Lifesciences
EW
|
+$120M |
| 5 |
Marathon Petroleum
MPC
|
+$92.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$210M |
| 2 |
HCA Healthcare
HCA
|
+$203M |
| 3 |
O'Reilly Automotive
ORLY
|
+$150M |
| 4 |
Expeditors International
EXPD
|
+$91M |
| 5 |
Adobe
ADBE
|
+$78.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.35% |
| 2 | Consumer Discretionary | 13.64% |
| 3 | Healthcare | 12.96% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBDS
876
DELISTED
Solo Brands Inc
SBDS
| $304K | ﹤0.01% |
+1,341
| New | +$333K |
|
877
Children's Place
PLCE
$53.6M
| $300K | ﹤0.01% |
+12,930
| New | +$329K |
|
878
Axogen
AXGN
$2.1B
| $300K | ﹤0.01% |
32,869
-2,605
| -7% | -$24.3K |
|
879
American Realty Investors
ARL
$239M
| $300K | ﹤0.01% |
13,771
+2,364
| +21% | +$45.4K |
|
|
HLGN
880
DELISTED
Heliogen, Inc.
HLGN
| $295K | ﹤0.01% |
+34,410
| New | +$315K |
|
881
Cadre Holdings
CDRE
$1.32B
| $294K | ﹤0.01% |
+13,479
| New | +$287K |
|
882
Royalty Pharma
RPRX
$26.1B
| $292K | ﹤0.01% |
+9,487
| New | +$321K |
|
883
Shattuck Labs
STTK
$710M
| $291K | ﹤0.01% |
93,331
-29,755
| -24% | -$86.3K |
|
884
Biglari Holdings Class B
BH
$1.2B
| $286K | ﹤0.01% |
1,451
| – | – |
|
885
Omnicell
OMCL
$1.86B
| $284K | ﹤0.01% |
+3,852
| New | +$260K |
|
886
Johnson Controls International
JCI
$87.5B
| $277K | ﹤0.01% |
+4,063
| New | +$250K |
|
887
Nabors Industries
NBR
$1.23B
| $276K | ﹤0.01% |
2,965
| – | – |
|
888
TaskUs
TASK
$506M
| $275K | ﹤0.01% |
+24,289
| New | +$295K |
|
889
L3Harris
LHX
$55.9B
| $274K | ﹤0.01% |
+1,401
| New | +$268K |
|
890
Archer Daniels Midland
ADM
$41.4B
| $274K | ﹤0.01% |
+3,620
| New | +$274K |
|
891
Dyne Therapeutics
DYN
$4.04B
| $273K | ﹤0.01% |
24,279
-204,542
| -89% | -$2.41M |
|
892
Bunge Global
BG
$23.6B
| $272K | ﹤0.01% |
2,881
-146
| -5% | -$13.6K |
|
893
Crown Castle
CCI
$32.7B
| $271K | ﹤0.01% |
+2,376
| New | +$283K |
|
894
Greenlight Captial
GLRE
$563M
| $271K | ﹤0.01% |
25,677
+387
| +2% | +$3.83K |
|
|
SGMO
895
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $270K | ﹤0.01% |
208,048
-313,943
| -60% | -$429K |
|
|
PGTI
896
DELISTED
PGT, Inc.
PGTI
| $268K | ﹤0.01% |
9,183
-38,391
| -81% | -$1.01M |
|
897
Third Coast Bancshares
TCBX
$709M
| $268K | ﹤0.01% |
16,861
+2,570
| +18% | +$39.9K |
|
|
VSXY
898
Victoria's Secret
VSXY
$6.64B
| $266K | ﹤0.01% |
15,260
-49,415
| -76% | -$1.25M |
|
899
Five Star Bancorp
FSBC
$1B
| $263K | ﹤0.01% |
+11,754
| New | +$239K |
|
900
Procept Biorobotics
PRCT
$950M
| $262K | ﹤0.01% |
7,409
-12,173
| -62% | -$402K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2023 Portfolio in Review
As of Q2 2023, Jacobs Levy Equity Management held 1,119 positions worth $17.4B, up 6.3% from $16.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jacobs Levy Equity Management's Q2 2023 filing shows 175 new, 316 increased, 445 reduced and 162 closed positions. Its largest new stake was Airbnb: 1,241,173 shares worth $159M. The largest sale was Netflix, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jacobs Levy Equity Management's largest Q2 2023 buy was Airbnb: 1,241,173 shares worth $159M.
- Jacobs Levy Equity Management added most to Humana in Q2 2023, an estimated $176M increase.
- Jacobs Levy Equity Management's biggest Q2 2023 reduction was Netflix, cutting an estimated $210M.
- Jacobs Levy Equity Management fully exited HCA Healthcare in Q2 2023, selling an estimated $203M.
- Jacobs Levy Equity Management's ten largest holdings make up 21% of its $17.4B portfolio in Q2 2023.
- Jacobs Levy Equity Management opened 175 new positions and closed 162 in Q2 2023.
- Jacobs Levy Equity Management's portfolio value rose 6.3% quarter-over-quarter to $17.4B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2023, filed 14 Aug 2023.